In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

NeoGenomics acquires Clarient for $277mm in cash and stock

Executive Summary

NeoGenomics Inc. is paying $277mm in cash and stock to buy Clarient Inc. and Clarient Diagnostics Services Inc. from GE Healthcare. The acquired companies bring a strong base of pathology services for solid tumor analysis, including testing for breast, colon, and lung cancers, as well as a $20mm clinical trial services business.
Deal Industry
  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Cytology
    • Molecular Diagnostics & Genetic Testing
  • Laboratory Testing Services
  • Research, Analytical Equipment & Supplies
    • PCR & Amplification Tools
Deal Status
  • Final
Deal Type
  • Acquisition
    • Acquisition of Private Biotech
    • Payment Includes Cash
    • Full Acquisition
    • Intra-Biotech Deal
    • Payment Includes Stock

Related Companies

Advertisement
UsernamePublicRestriction

Register